TdT (MSVA-453R)

Recombinant Rabbit monoclonal / IgG 1:100 Research Use Only Nucleus Human MSVA-453R Deoxynucleotidyltransferase terminal; DNTT; Nucleosidetriphosphate DNA Deoxynucleotidylexotransferase; TDT; Terminal addition enzyme; Terminal deoxynucleotidyltransferase; Terminal deoxyribonucleotidyltransferase Thymus: At least a moderate nuclear immunostaining should be seen in virtually all cortical lymphocytes of the normal thymus. Terminal deoxynucleotidyl transferase (TdT), also known as DNA nucleotidylexotransferase (DNTT) or terminal transferase, is a 58 kDa protein coded by the DNTT gene on 10q23-q24. It is a highly specialized template-independent DNA polymerase which is only expressed in immature, pre-B, pre-T lymphoid cells. In these cells TdT catalyzes the addition of N-nucleotides to the V, D, and J exons of the T-cell receptor (TCR) and B-cell receptor (TCR) genes which creates junctional diversity during antibody gene recombination. A high diversity of TCR and BCR is important for the diversity to antibody recognition sites and thus for the function of the immune system. Using antibody MSVA-453R , a moderate to strong nuclear staining is seen in the vast majority of cortical lymphocytes of the normal thymus while only scattered positive cells are present in the medulla of the thymus (especially in areas adjacent to the cortex). Few scattered lymphoid cells with strong TdT expression can be seen in the interfollicular area of lymph nodes and tonsils (especially in non-adult patients). Few scattered positive cells (hematogones) can also be seen in the bone marrow. These findings are largely consistent with the RNA data described in the Human Protein Atlas (Tissue expression TdT) . The data from the protein atlas are complemented by IHC images documenting TdT protein expression  in tissues. Suggested positive tissue control : Thymus: At least a moderate nuclear immunostaining should be seen in virtually all cortical lymphocytes of the normal thymus. Suggested negative tissue control: Thymus: The vast majority of the medullary lymphocytes of the normal thy... Almost all pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) show strong and diffuse TdT immunostaining. An often weak and only focal TdT positivity can also be seen in acute myelogenous leukemia / myeloid sarcoma, blastic plasmacytoid dendritic cell neoplasm, Burkitt lymphoma, as well as in some indolent T cell proliferations. Positive TdT immunostaining is seen in the vast majority of lymphocyte predominant thymomas and in  40-50% of Merkel cell carcinomas. The TCGA findings on TdT RNA expression in different tumor categories have been summarized in the Human Protein Atlas. Strong TdT immunostaining of lymphocytes in a thymoma. Merkel cell carcinoma with moderate to strong TdT immunostaining in >80% of tumor cells. Merkel cell carcinoma with strong TdT positivity in <5% of tumor cells. Cancer tissue gallery No data available at the moment IHC users have different preferences on how the stains should look like. Some prefer high staining intensity of the target stain and even accept some background. Others favor absolute specificity and lighter target stains. Factors that invariably lead to more intense staining include higher concentration of the antibody and visualization tools, longer incubation time, higher temperature during incubation, higher temperature and longer duration of the heat induced epitope retrieval (slide pretreatment). The impact of the pH during slide pretreatment has variable effects and depends on the antibody and the target protein. Accordingly, multiple different protocols can generate identical staining results. All images and data shown here and in our image galleries are obtained by the manual protocol described below. Other protocols resulting in equivalent staining are described as well. -Manual protocol Freshly cut sections should be used (less than 10 days between cutting and staining). Hea... TdT expression has also been described in non-hematological neoplasias. The role of TdT in these neoplasms is unclear. Many tumor types have so far not been analyzed for TdT expression. Specificity of MSVA-453R is documented by strong positive staining in cell types that are well documented to express TdT such cortical thymocytes and scattered cells in lymph nodes and tonsils while staining was absent in all tissues known to not express TdT including tissues notorious for non-specific IHC background such as kidney, colonic mucosa, and epidermis. Normal tissue gallery